River Street Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-615
| Closed | -$390K | – | 169 |
|
|
2025
Q1 | $390K | Buy |
615
+62
| +11% | +$39.3K | 0.19% | 105 |
|
|
2024
Q4 | $394K | Buy |
553
+41
| +8% | +$29.2K | 0.2% | 104 |
|
|
2024
Q3 | $538K | Buy |
512
+8
| +2% | +$8.41K | 0.29% | 86 |
|
|
2024
Q2 | $530K | Buy |
504
+44
| +10% | +$46.2K | 0.33% | 85 |
|
|
2024
Q1 | $443K | Buy |
460
+30
| +7% | +$28.9K | 0.3% | 87 |
|
|
2023
Q4 | $378K | Sell |
430
-57
| -12% | -$50.1K | 0.3% | 83 |
|
|
2023
Q3 | $401K | Buy |
487
+22
| +5% | +$18.1K | 0.38% | 80 |
|
|
2023
Q2 | $334K | Sell |
465
-9
| -2% | -$6.47K | 0.32% | 86 |
|
|
2023
Q1 | $389K | Buy |
474
+14
| +3% | +$11.5K | 0.38% | 79 |
|
|
2022
Q4 | $332K | Buy |
+460
| New | +$332K | 0.36% | 82 |
|